Teva Pharmaceutical Industries Limited American Depositary Shares · Depreciation & Amortization

Latest reported$989.00Mperiod endingJun 30, 2026

TEVA Depreciation & Amortization ($13.80M → $989.00M)

Annual Depreciation & Amortization

High-resolution chart · PNG

TEVA depreciation & amortization history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Depreciation & Amortization — Annual fiscal periods (USD)
Period ending	Depreciation & Amortization (USD)
Dec 31, 2025	1,002,000,000
Dec 31, 2024	1,059,000,000
Dec 31, 2023	1,153,000,000
Dec 31, 2022	1,308,000,000
Dec 31, 2021	1,330,000,000
Dec 31, 2020	1,557,000,000
Dec 31, 2019	1,722,000,000
Dec 31, 2018	1,842,000,000
Dec 31, 2017	2,112,000,000
Dec 31, 2016	1,524,000,000
Dec 31, 2015	1,308,000,000
Dec 31, 2014	1,508,000,000
Dec 31, 2013	1,642,000,000
Dec 31, 2012	1,708,000,000
Dec 31, 2011	1,069,000,000
Dec 31, 2010	977,000,000
Dec 31, 2009	908,000,000
Dec 31, 2008	493,000,000
Dec 31, 2007	521,000,000
Dec 31, 2006	431,000,000
Dec 31, 2005	242,500,000
Dec 31, 2004	220,400,000
Dec 31, 2003	127,700,000
Dec 31, 2002	96,900,000
Dec 31, 2001	109,129,000
Dec 31, 2000	94,985,000
Dec 31, 1999	68,424,000
Dec 31, 1998	58,700,000
Dec 31, 1997	52,000,000
Dec 31, 1996	43,700,000
Dec 31, 1995	25,400,000
Dec 31, 1994	23,500,000
Dec 31, 1993	19,600,000
Dec 31, 1992	18,600,000
Dec 31, 1991	13,800,000